Industry Research Reports
Home > Reports > Food & Beverages > OPO-containing Infant Formulas - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
OPO-containing Infant Formulas - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Food & Beverages
Published Date: 2025-03-13
Pages: 118 Pages
Report ld: 4662251
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
OPO-containing Infant Formulas Market Size(US$)
CAGR 2025-2031
5%
Market Size,2031
USD 1,497
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,117 million
Market Forecast in 2031(Value)
US$ 1,497 million
CAGR
5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
North American market for OPO-containing Infant Formulas was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for OPO-containing Infant Formulas was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for OPO-containing Infant Formulas was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for OPO-containing Infant Formulas, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of OPO-containing Infant Formulas by region & country, by Type, and by Application.
The OPO-containing Infant Formulas market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OPO-containing Infant Formulas.
MARKET SEGMENTATION
By Company
- BiosTime
- Nutriben
- Ausnutria
- HERDS
- Milupa
- Shanxi Yatai
- Beingmate
- Abbott
- Brightdairy
- Feihe
- Wyeth Nutrition
- Deloraine
- Yili
- Kabrita
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cow Milk Formula
- Goat Milk Formula
Segment by Application
- 0 - 6 Month
- 6 - 12 Month
- 12 - 36 Month
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of OPO-containing Infant Formulas manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of OPO-containing Infant Formulas in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of OPO-containing Infant Formulas in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 OPO-containing Infant Formulas Product Introduction
1.2 Global OPO-containing Infant Formulas Market Size Forecast
1.2.1 Global OPO-containing Infant Formulas Sales Value (2020-2031)
1.2.2 Global OPO-containing Infant Formulas Sales Volume (2020-2031)
1.2.3 Global OPO-containing Infant Formulas Sales Price (2020-2031)
1.3 OPO-containing Infant Formulas Market Trends & Drivers
1.3.1 OPO-containing Infant Formulas Industry Trends
1.3.2 OPO-containing Infant Formulas Market Drivers & Opportunity
1.3.3 OPO-containing Infant Formulas Market Challenges
1.3.4 OPO-containing Infant Formulas Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global OPO-containing Infant Formulas Players Revenue Ranking (2024)
2.2 Global OPO-containing Infant Formulas Revenue by Company (2020-2025)
2.3 Global OPO-containing Infant Formulas Players Sales Volume Ranking (2024)
2.4 Global OPO-containing Infant Formulas Sales Volume by Company Players (2020-2025)
2.5 Global OPO-containing Infant Formulas Average Price by Company (2020-2025)
2.6 Key Manufacturers OPO-containing Infant Formulas Manufacturing Base and Headquarters
2.7 Key Manufacturers OPO-containing Infant Formulas Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of OPO-containing Infant Formulas
2.9 OPO-containing Infant Formulas Market Competitive Analysis
2.9.1 OPO-containing Infant Formulas Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by OPO-containing Infant Formulas Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OPO-containing Infant Formulas as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cow Milk Formula
3.1.2 Goat Milk Formula
3.2 Global OPO-containing Infant Formulas Sales Value by Type
3.2.1 Global OPO-containing Infant Formulas Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global OPO-containing Infant Formulas Sales Value, by Type (2020-2031)
3.2.3 Global OPO-containing Infant Formulas Sales Value, by Type (%) (2020-2031)
3.3 Global OPO-containing Infant Formulas Sales Volume by Type
3.3.1 Global OPO-containing Infant Formulas Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global OPO-containing Infant Formulas Sales Volume, by Type (2020-2031)
3.3.3 Global OPO-containing Infant Formulas Sales Volume, by Type (%) (2020-2031)
3.4 Global OPO-containing Infant Formulas Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 0 - 6 Month
4.1.2 6 - 12 Month
4.1.3 12 - 36 Month
4.2 Global OPO-containing Infant Formulas Sales Value by Application
4.2.1 Global OPO-containing Infant Formulas Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global OPO-containing Infant Formulas Sales Value, by Application (2020-2031)
4.2.3 Global OPO-containing Infant Formulas Sales Value, by Application (%) (2020-2031)
4.3 Global OPO-containing Infant Formulas Sales Volume by Application
4.3.1 Global OPO-containing Infant Formulas Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global OPO-containing Infant Formulas Sales Volume, by Application (2020-2031)
4.3.3 Global OPO-containing Infant Formulas Sales Volume, by Application (%) (2020-2031)
4.4 Global OPO-containing Infant Formulas Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global OPO-containing Infant Formulas Sales Value by Region
5.1.1 Global OPO-containing Infant Formulas Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global OPO-containing Infant Formulas Sales Value by Region (2020-2025)
5.1.3 Global OPO-containing Infant Formulas Sales Value by Region (2026-2031)
5.1.4 Global OPO-containing Infant Formulas Sales Value by Region (%), (2020-2031)
5.2 Global OPO-containing Infant Formulas Sales Volume by Region
5.2.1 Global OPO-containing Infant Formulas Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global OPO-containing Infant Formulas Sales Volume by Region (2020-2025)
5.2.3 Global OPO-containing Infant Formulas Sales Volume by Region (2026-2031)
5.2.4 Global OPO-containing Infant Formulas Sales Volume by Region (%), (2020-2031)
5.3 Global OPO-containing Infant Formulas Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America OPO-containing Infant Formulas Sales Value, 2020-2031
5.4.2 North America OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe OPO-containing Infant Formulas Sales Value, 2020-2031
5.5.2 Europe OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific OPO-containing Infant Formulas Sales Value, 2020-2031
5.6.2 Asia Pacific OPO-containing Infant Formulas Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America OPO-containing Infant Formulas Sales Value, 2020-2031
5.7.2 South America OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa OPO-containing Infant Formulas Sales Value, 2020-2031
5.8.2 Middle East & Africa OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions OPO-containing Infant Formulas Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions OPO-containing Infant Formulas Sales Value and Sales Volume
6.2.1 Key Countries/Regions OPO-containing Infant Formulas Sales Value, 2020-2031
6.2.2 Key Countries/Regions OPO-containing Infant Formulas Sales Volume, 2020-2031
6.3 United States
6.3.1 United States OPO-containing Infant Formulas Sales Value, 2020-2031
6.3.2 United States OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.3.3 United States OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe OPO-containing Infant Formulas Sales Value, 2020-2031
6.4.2 Europe OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China OPO-containing Infant Formulas Sales Value, 2020-2031
6.5.2 China OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.5.3 China OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan OPO-containing Infant Formulas Sales Value, 2020-2031
6.6.2 Japan OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea OPO-containing Infant Formulas Sales Value, 2020-2031
6.7.2 South Korea OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia OPO-containing Infant Formulas Sales Value, 2020-2031
6.8.2 Southeast Asia OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India OPO-containing Infant Formulas Sales Value, 2020-2031
6.9.2 India OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
6.9.3 India OPO-containing Infant Formulas Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BiosTime
7.1.1 BiosTime Company Information
7.1.2 BiosTime Introduction and Business Overview
7.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BiosTime OPO-containing Infant Formulas Product Offerings
7.1.5 BiosTime Recent Development
7.2 Nutriben
7.2.1 Nutriben Company Information
7.2.2 Nutriben Introduction and Business Overview
7.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Nutriben OPO-containing Infant Formulas Product Offerings
7.2.5 Nutriben Recent Development
7.3 Ausnutria
7.3.1 Ausnutria Company Information
7.3.2 Ausnutria Introduction and Business Overview
7.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Ausnutria OPO-containing Infant Formulas Product Offerings
7.3.5 Ausnutria Recent Development
7.4 HERDS
7.4.1 HERDS Company Information
7.4.2 HERDS Introduction and Business Overview
7.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 HERDS OPO-containing Infant Formulas Product Offerings
7.4.5 HERDS Recent Development
7.5 Milupa
7.5.1 Milupa Company Information
7.5.2 Milupa Introduction and Business Overview
7.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Milupa OPO-containing Infant Formulas Product Offerings
7.5.5 Milupa Recent Development
7.6 Shanxi Yatai
7.6.1 Shanxi Yatai Company Information
7.6.2 Shanxi Yatai Introduction and Business Overview
7.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Shanxi Yatai OPO-containing Infant Formulas Product Offerings
7.6.5 Shanxi Yatai Recent Development
7.7 Beingmate
7.7.1 Beingmate Company Information
7.7.2 Beingmate Introduction and Business Overview
7.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Beingmate OPO-containing Infant Formulas Product Offerings
7.7.5 Beingmate Recent Development
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Introduction and Business Overview
7.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Abbott OPO-containing Infant Formulas Product Offerings
7.8.5 Abbott Recent Development
7.9 Brightdairy
7.9.1 Brightdairy Company Information
7.9.2 Brightdairy Introduction and Business Overview
7.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Brightdairy OPO-containing Infant Formulas Product Offerings
7.9.5 Brightdairy Recent Development
7.10 Feihe
7.10.1 Feihe Company Information
7.10.2 Feihe Introduction and Business Overview
7.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Feihe OPO-containing Infant Formulas Product Offerings
7.10.5 Feihe Recent Development
7.11 Wyeth Nutrition
7.11.1 Wyeth Nutrition Company Information
7.11.2 Wyeth Nutrition Introduction and Business Overview
7.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Wyeth Nutrition OPO-containing Infant Formulas Product Offerings
7.11.5 Wyeth Nutrition Recent Development
7.12 Deloraine
7.12.1 Deloraine Company Information
7.12.2 Deloraine Introduction and Business Overview
7.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Deloraine OPO-containing Infant Formulas Product Offerings
7.12.5 Deloraine Recent Development
7.13 Yili
7.13.1 Yili Company Information
7.13.2 Yili Introduction and Business Overview
7.13.3 Yili OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Yili OPO-containing Infant Formulas Product Offerings
7.13.5 Yili Recent Development
7.14 Kabrita
7.14.1 Kabrita Company Information
7.14.2 Kabrita Introduction and Business Overview
7.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Kabrita OPO-containing Infant Formulas Product Offerings
7.14.5 Kabrita Recent Development
8 Industry Chain Analysis
8.1 OPO-containing Infant Formulas Industrial Chain
8.2 OPO-containing Infant Formulas Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 OPO-containing Infant Formulas Sales Model
8.5.2 Sales Channel
8.5.3 OPO-containing Infant Formulas Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. OPO-containing Infant Formulas Market Trends
Table 2. OPO-containing Infant Formulas Market Drivers & Opportunity
Table 3. OPO-containing Infant Formulas Market Challenges
Table 4. OPO-containing Infant Formulas Market Restraints
Table 5. Global OPO-containing Infant Formulas Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global OPO-containing Infant Formulas Revenue Market Share by Company (2020-2025)
Table 7. Global OPO-containing Infant Formulas Sales Volume by Company (2020-2025) & (K MT)
Table 8. Global OPO-containing Infant Formulas Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market OPO-containing Infant Formulas Price by Company (2020-2025) & (USD/MT)
Table 10. Key Manufacturers OPO-containing Infant Formulas Manufacturing Base and Headquarters
Table 11. Key Manufacturers OPO-containing Infant Formulas Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of OPO-containing Infant Formulas
Table 13. Global OPO-containing Infant Formulas Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OPO-containing Infant Formulas as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global OPO-containing Infant Formulas Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global OPO-containing Infant Formulas Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global OPO-containing Infant Formulas Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global OPO-containing Infant Formulas Sales Market Share in Value by Type (2020-2025)
Table 20. Global OPO-containing Infant Formulas Sales Market Share in Value by Type (2026-2031)
Table 21. Global OPO-containing Infant Formulas Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)
Table 22. Global OPO-containing Infant Formulas Sales Volume by Type (2020-2025) & (K MT)
Table 23. Global OPO-containing Infant Formulas Sales Volume by Type (2026-2031) & (K MT)
Table 24. Global OPO-containing Infant Formulas Sales Market Share in Volume by Type (2020-2025)
Table 25. Global OPO-containing Infant Formulas Sales Market Share in Volume by Type (2026-2031)
Table 26. Global OPO-containing Infant Formulas Price by Type (2020-2025) & (USD/MT)
Table 27. Global OPO-containing Infant Formulas Price by Type (2026-2031) & (USD/MT)
Table 28. Global OPO-containing Infant Formulas Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global OPO-containing Infant Formulas Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global OPO-containing Infant Formulas Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global OPO-containing Infant Formulas Sales Market Share in Value by Application (2020-2025)
Table 32. Global OPO-containing Infant Formulas Sales Market Share in Value by Application (2026-2031)
Table 33. Global OPO-containing Infant Formulas Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)
Table 34. Global OPO-containing Infant Formulas Sales Volume by Application (2020-2025) & (K MT)
Table 35. Global OPO-containing Infant Formulas Sales Volume by Application (2026-2031) & (K MT)
Table 36. Global OPO-containing Infant Formulas Sales Market Share in Volume by Application (2020-2025)
Table 37. Global OPO-containing Infant Formulas Sales Market Share in Volume by Application (2026-2031)
Table 38. Global OPO-containing Infant Formulas Price by Application (2020-2025) & (USD/MT)
Table 39. Global OPO-containing Infant Formulas Price by Application (2026-2031) & (USD/MT)
Table 40. Global OPO-containing Infant Formulas Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global OPO-containing Infant Formulas Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global OPO-containing Infant Formulas Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global OPO-containing Infant Formulas Sales Value by Region (2020-2025) & (%)
Table 44. Global OPO-containing Infant Formulas Sales Value by Region (2026-2031) & (%)
Table 45. Global OPO-containing Infant Formulas Sales Volume by Region (K MT): 2020 VS 2024 VS 2031
Table 46. Global OPO-containing Infant Formulas Sales Volume by Region (2020-2025) & (K MT)
Table 47. Global OPO-containing Infant Formulas Sales Volume by Region (2026-2031) & (K MT)
Table 48. Global OPO-containing Infant Formulas Sales Volume by Region (2020-2025) & (%)
Table 49. Global OPO-containing Infant Formulas Sales Volume by Region (2026-2031) & (%)
Table 50. Global OPO-containing Infant Formulas Average Price by Region (2020-2025) & (USD/MT)
Table 51. Global OPO-containing Infant Formulas Average Price by Region (2026-2031) & (USD/MT)
Table 52. Key Countries/Regions OPO-containing Infant Formulas Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions OPO-containing Infant Formulas Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions OPO-containing Infant Formulas Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions OPO-containing Infant Formulas Sales Volume, (2020-2025) & (K MT)
Table 56. Key Countries/Regions OPO-containing Infant Formulas Sales Volume, (2026-2031) & (K MT)
Table 57. BiosTime Company Information
Table 58. BiosTime Introduction and Business Overview
Table 59. BiosTime OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. BiosTime OPO-containing Infant Formulas Product Offerings
Table 61. BiosTime Recent Development
Table 62. Nutriben Company Information
Table 63. Nutriben Introduction and Business Overview
Table 64. Nutriben OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 65. Nutriben OPO-containing Infant Formulas Product Offerings
Table 66. Nutriben Recent Development
Table 67. Ausnutria Company Information
Table 68. Ausnutria Introduction and Business Overview
Table 69. Ausnutria OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Ausnutria OPO-containing Infant Formulas Product Offerings
Table 71. Ausnutria Recent Development
Table 72. HERDS Company Information
Table 73. HERDS Introduction and Business Overview
Table 74. HERDS OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. HERDS OPO-containing Infant Formulas Product Offerings
Table 76. HERDS Recent Development
Table 77. Milupa Company Information
Table 78. Milupa Introduction and Business Overview
Table 79. Milupa OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Milupa OPO-containing Infant Formulas Product Offerings
Table 81. Milupa Recent Development
Table 82. Shanxi Yatai Company Information
Table 83. Shanxi Yatai Introduction and Business Overview
Table 84. Shanxi Yatai OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Shanxi Yatai OPO-containing Infant Formulas Product Offerings
Table 86. Shanxi Yatai Recent Development
Table 87. Beingmate Company Information
Table 88. Beingmate Introduction and Business Overview
Table 89. Beingmate OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Beingmate OPO-containing Infant Formulas Product Offerings
Table 91. Beingmate Recent Development
Table 92. Abbott Company Information
Table 93. Abbott Introduction and Business Overview
Table 94. Abbott OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Abbott OPO-containing Infant Formulas Product Offerings
Table 96. Abbott Recent Development
Table 97. Brightdairy Company Information
Table 98. Brightdairy Introduction and Business Overview
Table 99. Brightdairy OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Brightdairy OPO-containing Infant Formulas Product Offerings
Table 101. Brightdairy Recent Development
Table 102. Feihe Company Information
Table 103. Feihe Introduction and Business Overview
Table 104. Feihe OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Feihe OPO-containing Infant Formulas Product Offerings
Table 106. Feihe Recent Development
Table 107. Wyeth Nutrition Company Information
Table 108. Wyeth Nutrition Introduction and Business Overview
Table 109. Wyeth Nutrition OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Wyeth Nutrition OPO-containing Infant Formulas Product Offerings
Table 111. Wyeth Nutrition Recent Development
Table 112. Deloraine Company Information
Table 113. Deloraine Introduction and Business Overview
Table 114. Deloraine OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 115. Deloraine OPO-containing Infant Formulas Product Offerings
Table 116. Deloraine Recent Development
Table 117. Yili Company Information
Table 118. Yili Introduction and Business Overview
Table 119. Yili OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 120. Yili OPO-containing Infant Formulas Product Offerings
Table 121. Yili Recent Development
Table 122. Kabrita Company Information
Table 123. Kabrita Introduction and Business Overview
Table 124. Kabrita OPO-containing Infant Formulas Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 125. Kabrita OPO-containing Infant Formulas Product Offerings
Table 126. Kabrita Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. OPO-containing Infant Formulas Downstream Customers
Table 130. OPO-containing Infant Formulas Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. OPO-containing Infant Formulas Product Picture
Figure 2. Global OPO-containing Infant Formulas Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global OPO-containing Infant Formulas Sales Value (2020-2031) & (US$ Million)
Figure 4. Global OPO-containing Infant Formulas Sales Volume (2020-2031) & (K MT)
Figure 5. Global OPO-containing Infant Formulas Sales Price (2020-2031) & (USD/MT)
Figure 6. OPO-containing Infant Formulas Report Years Considered
Figure 7. Global OPO-containing Infant Formulas Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global OPO-containing Infant Formulas Players Sales Volume Ranking (2024) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by OPO-containing Infant Formulas Revenue in 2024
Figure 10. OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Cow Milk Formula Picture
Figure 12. Goat Milk Formula Picture
Figure 13. Global OPO-containing Infant Formulas Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global OPO-containing Infant Formulas Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global OPO-containing Infant Formulas Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)
Figure 16. Global OPO-containing Infant Formulas Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global OPO-containing Infant Formulas Price by Type (2020-2031) & (USD/MT)
Figure 18. Product Picture of 0 - 6 Month
Figure 19. Product Picture of 6 - 12 Month
Figure 20. Product Picture of 12 - 36 Month
Figure 21. Global OPO-containing Infant Formulas Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global OPO-containing Infant Formulas Sales Value Market Share by Application, 2024 & 2031
Figure 23. Global OPO-containing Infant Formulas Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)
Figure 24. Global OPO-containing Infant Formulas Sales Volume Market Share by Application, 2024 & 2031
Figure 25. Global OPO-containing Infant Formulas Price by Application (2020-2031) & (USD/MT)
Figure 26. North America OPO-containing Infant Formulas Sales Value (2020-2031) & (US$ Million)
Figure 27. North America OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
Figure 28. Europe OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 29. Europe OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
Figure 30. Asia Pacific OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 31. Asia Pacific OPO-containing Infant Formulas Sales Value by Region (%), 2024 VS 2031
Figure 32. South America OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 33. South America OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
Figure 34. Middle East & Africa OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 35. Middle East & Africa OPO-containing Infant Formulas Sales Value by Country (%), 2024 VS 2031
Figure 36. Key Countries/Regions OPO-containing Infant Formulas Sales Value (%), (2020-2031)
Figure 37. Key Countries/Regions OPO-containing Infant Formulas Sales Volume (%), (2020-2031)
Figure 38. United States OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 39. United States OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 40. United States OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 41. Europe OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 42. Europe OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 43. Europe OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 44. China OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 45. China OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 46. China OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 47. Japan OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 48. Japan OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 49. Japan OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 50. South Korea OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 51. South Korea OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 52. South Korea OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 53. Southeast Asia OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 54. Southeast Asia OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 55. Southeast Asia OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 56. India OPO-containing Infant Formulas Sales Value, (2020-2031) & (US$ Million)
Figure 57. India OPO-containing Infant Formulas Sales Value by Type (%), 2024 VS 2031
Figure 58. India OPO-containing Infant Formulas Sales Value by Application (%), 2024 VS 2031
Figure 59. OPO-containing Infant Formulas Industrial Chain
Figure 60. OPO-containing Infant Formulas Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global OPO-containing Infant Formulas market size from 2025 to 2031?
The annual compound growth rate of the global OPO-containing Infant Formulas market is 5% 2025 to 2031.
What was the global market size of OPO-containing Infant Formulas in 2025?
Which region is expected to have the highest market share?
What was the global market size of OPO-containing Infant Formulas in 2031?
Which companies rank high in the global OPO-containing Infant Formulas market?
Related Reports
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2032
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 157
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 94
USD 4250.00
(Single User License)
OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2026
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 125
USD 2900.00
(Single User License)
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2031
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 158
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 96
USD 4250.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2025
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-13
Pages: 93
USD 2900.00
(Single User License)
OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 112
USD 3950.00
(Single User License)
Global OPO-containing Infant Formulas Market Insights, Forecast to 2030
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 165
USD 4900.00
(Single User License)
Global OPO-containing Infant Formulas Market Research Report 2024
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 89
USD 2900.00
(Single User License)
Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2032
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 157
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 94
USD 4250.00 (Single User License)OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2026
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 125
USD 2900.00 (Single User License)Global OPO-containing Infant Formulas Market Outlook, In‑Depth Analysis & Forecast to 2031
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 158
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 96
USD 4250.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2025
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-13
Pages: 93
USD 2900.00 (Single User License)OPO-containing Infant Formulas- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 112
USD 3950.00 (Single User License)Global OPO-containing Infant Formulas Market Insights, Forecast to 2030
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 165
USD 4900.00 (Single User License)Global OPO-containing Infant Formulas Market Research Report 2024
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 89
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now